Table 2.

Left ventricular end-diastolic diameter across categories of ¹⁸FDG uptake at each ¹⁸FDG-PET scan

	LV-SUV	LVEDD (mm)	P
PETSTAGING	Low	47.3 ± 5.2	0.81
	High	47.7 ± 5.2
PETINTERIM	Low	46.1 ± 4..9	0.11
	High	48.7 ± 5.2
PETEOT	Low	47.7 ± 4.8	0.90
	High	47.7 ± 5.1

Left ventricular end-diastolic diameter (LVEDD), as assessed by echocardiography performed after completion of anthracycline chemotherapy, in patients with myocardial ¹⁸FDG standardized uptake values (LV-SUV) below or above the median value (low and high, respectively) measured at each ¹⁸FDG positron emission tomography (¹⁸FDG-PET) scan

For each PET time point, LVEDD was compared between patients with LV-SUV below vs. above the median value by unpaired t-test

LV-SUV^STAGING: LV-SUV at the ¹⁸FDG-PET scan before treatment; LV-SUV^INTERIM: LV-SUV at the ¹⁸FDG-PET performed after 2 cycles of doxorubicin; LV-SUV^EOT: LV-SUV at the ¹⁸FDG-PET performed at the end of chemotherapy